Gotham Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $750K | Buy |
88,491
+5,455
| +7% | +$46.2K | ﹤0.01% | 1217 |
|
2025
Q1 | $668K | Buy |
83,036
+38,040
| +85% | +$306K | 0.01% | 1132 |
|
2024
Q4 | $404K | Buy |
44,996
+3,655
| +9% | +$32.8K | ﹤0.01% | 1191 |
|
2024
Q3 | $303K | Buy |
41,341
+1,049
| +3% | +$7.69K | ﹤0.01% | 1218 |
|
2024
Q2 | $230K | Buy |
+40,292
| New | +$230K | ﹤0.01% | 1298 |
|
2023
Q3 | – | Sell |
-39,733
| Closed | -$385K | – | 1325 |
|
2023
Q2 | $385K | Sell |
39,733
-55,147
| -58% | -$534K | 0.01% | 1050 |
|
2023
Q1 | $1.04M | Buy |
+94,880
| New | +$1.04M | 0.03% | 731 |
|